🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Italy / NCT07416513
Recruiting Not applicable

Digital Solutions for bEtter cAre

NCT07416513 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-05-14
Last updated
2026-02-18

Condition(s) studied

Cancer Diagnosis

Investigational drug(s) / intervention(s)

Patients, survivors, caregivers, family members and healthcare professionals

Patients, survivors, caregivers, family members and healthcare professionals: Focus group discussions (FGD) and completion of survey

Study summary

The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.

Eligibility

Sex
ALL
Min age
12 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: HEALTHCARE PROFESSIONALS: * Healthcare professionals actually working in oncology and/or psychooncology; * Teachers of paediatric cancer patients. ADULT POPULATION: * Patients with a current or previous cancer diagnosis * Adequate language proficiency, * Able to provide informed consent; PAEDIATRIC POPULATION: * Older than 12 years of age; * Patients with a current or previous cancer diagnosis; * Adequate language proficiency; * Legal guardians of paediatric cancer patients able to provide informed consent. CAREGIVERS: * Caregivers and/or family members of cancer patients who lived or assist the loved ones with a current or previous cancer diagnosis in the cancer journey; * Adequate language proficiency; * Able to provide informed consent; * Caregivers and/or family members of paediatric cancer patients under 12 years of age. Exclusion Criteria: * Healthcare professionals with limited oncology patient contact; * Insufficient knowledge of the local language; * Severe cognitive impairment, and/or mental disorders that prohibited their participation in the study or inadequate verbal skills that may render them incapable of informed consent (as evaluated by the clinician); * Inability to understand the study materials (as evaluated by the clinician); * Physical or psychological impairment that prohibits their participation in focus groups (as evaluated by the clinician).

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Centre François Baclesse Caen France Recruiting
Saarland University Homburg Germany Not Yet Recruiting
European Institute of Oncology Milan Italy Not Yet Recruiting
National Cancer Institute Vilnius Lithuania Not Yet Recruiting
Catalan Institute of Oncology Barcelona Spain Not Yet Recruiting

More European Institute of Oncology trials in Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07416513 on ClinicalTrials.gov ↗ ← All trials in Italy